Sonoma Pharmaceuticals Inc
(SNOA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Sales | 14,288 | 12,735 | 13,272 | 12,628 | 18,629 |
| Cost of Goods | 8,823 | 7,990 | 8,795 | 8,635 | 12,070 |
| Gross Profit | 5,465 | 4,745 | 4,477 | 3,993 | 6,559 |
| Operating Expenses | 9,998 | 10,436 | 9,842 | 10,515 | 10,078 |
| Operating Income | -3,710 | -4,701 | -4,570 | -5,887 | -3,449 |
| Other Income | 803 | -330 | -614 | 469 | -453 |
| Pre-tax Income | -2,907 | -5,031 | -5,184 | -5,418 | -3,902 |
| Income Tax | 550 | -196 | -33 | -332 | 713 |
| Net Income Continuous | -3,457 | -4,835 | -5,151 | -5,086 | -4,615 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 665 |
| Net Income | $-3,457 | $-4,835 | $-5,151 | $-5,086 | $-3,950 |
| EPS Basic Total Ops | -2.79 | -10.63 | -30.40 | -38.40 | -39.40 |
| EPS Basic Continuous Ops | -2.79 | -10.63 | -30.35 | -38.34 | -46.20 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 6.60 |
| EPS Diluted Total Ops | -2.79 | -10.63 | -30.40 | -38.40 | -39.40 |
| EPS Diluted Continuous Ops | -2.79 | -10.63 | -30.35 | -38.34 | -46.20 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 6.60 |
| EPS Diluted Before Non-Recurring Items | -2.25 | -7.60 | -21.80 | -38.40 | -46.20 |
| EBITDA(a) | $-3,572 | $-4,525 | $-4,445 | $-5,701 | $-3,222 |